Linear atrophoderma of Moulin
| Linear atrophoderma of Moulin | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Hyperpigmentation, atrophy |
| Complications | N/A |
| Onset | Childhood or adolescence |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown |
| Risks | |
| Diagnosis | Clinical diagnosis |
| Differential diagnosis | Linear scleroderma, Morphea |
| Prevention | N/A |
| Treatment | None specific |
| Medication | N/A |
| Prognosis | Generally benign |
| Frequency | Rare |
| Deaths | N/A |
Linear Atrophoderma of Moulin is a rare, idiopathic, acquired, linear dermatosis that was first described by Moulin et al. in 1992. It is characterized by hyperpigmented, atrophic, linear bands that follow the lines of Blaschko. The onset is usually in childhood or early adolescence. The pathogenesis of this condition is unknown.
Clinical Features[edit]
The clinical features of Linear Atrophoderma of Moulin include the following:
- Onset: The onset is usually in childhood or early adolescence.
- Lesions: The lesions are hyperpigmented, atrophic, linear bands that follow the lines of Blaschko.
- Distribution: The distribution of the lesions is usually unilateral and segmental. The trunk and limbs are the most commonly affected areas.
- Symptoms: The condition is usually asymptomatic.
Diagnosis[edit]
The diagnosis of Linear Atrophoderma of Moulin is primarily clinical, based on the characteristic appearance of the lesions and their distribution. Histopathological examination of the lesions shows a decrease in the amount of subcutaneous fat and dermal collagen, with no inflammation or changes in the overlying epidermis.
Treatment[edit]
There is no specific treatment for Linear Atrophoderma of Moulin. Management is primarily supportive, with the aim of improving the cosmetic appearance of the lesions. Options may include the use of topical corticosteroids, calcineurin inhibitors, and cosmetic camouflage.
Prognosis[edit]
The prognosis of Linear Atrophoderma of Moulin is generally good. The condition is not associated with any systemic involvement or malignancy. However, the cosmetic impact of the lesions can be significant.
See Also[edit]
References[edit]
<references />
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian